Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$73.1 - $97.93 $2,339 - $3,133
32 Added 0.1%
33,053 $3.21 Million
Q3 2023

Nov 13, 2023

SELL
$80.15 - $92.62 $26.8 Million - $30.9 Million
-333,754 Reduced 91.0%
33,021 $2.67 Million
Q2 2023

Dec 12, 2023

BUY
$91.49 - $104.64 $30.5 Million - $34.9 Million
333,717 Added 1010.62%
366,738 $33.8 Million
Q2 2023

Aug 08, 2023

SELL
$91.49 - $104.64 $329,089 - $376,390
-3,597 Reduced 0.97%
366,775 $33.9 Million
Q1 2023

Dec 12, 2023

BUY
$92.92 - $109.35 $31 Million - $36.5 Million
333,949 Added 1011.32%
366,970 $35.5 Million
Q1 2023

May 01, 2023

SELL
$92.92 - $109.35 $2.09 Million - $2.46 Million
-22,453 Reduced 5.72%
370,372 $35.8 Million
Q4 2022

Feb 03, 2023

SELL
$84.9 - $102.89 $4,414 - $5,350
-52 Reduced 0.01%
392,825 $38.3 Million
Q3 2022

Nov 08, 2022

SELL
$90.51 - $207.38 $18,283 - $41,890
-202 Reduced 0.05%
392,877 $36 Million
Q2 2022

Aug 09, 2022

BUY
$87.94 - $101.67 $17,939 - $20,740
204 Added 0.05%
393,079 $36.4 Million
Q1 2022

May 05, 2022

BUY
$85.56 - $107.12 $1.82 Million - $2.27 Million
21,230 Added 5.71%
392,875 $39.6 Million
Q4 2021

Feb 02, 2022

SELL
$97.41 - $116.74 $22,209 - $26,616
-228 Reduced 0.06%
371,645 $39.3 Million
Q3 2021

Oct 26, 2021

BUY
$101.72 - $114.56 $4.11 Million - $4.63 Million
40,376 Added 12.18%
371,873 $39.4 Million
Q2 2021

Jul 27, 2021

SELL
$100.62 - $116.66 $322,688 - $374,128
-3,207 Reduced 0.96%
331,497 $35.5 Million
Q1 2021

Apr 27, 2021

SELL
$95.11 - $111.11 $168,154 - $196,442
-1,768 Reduced 0.53%
334,704 $33.7 Million
Q4 2020

Jan 29, 2021

SELL
$101.34 - $117.74 $14,795 - $17,190
-146 Reduced 0.04%
336,472 $36.8 Million
Q3 2020

Nov 10, 2020

BUY
$95.79 - $111.95 $40,136 - $46,907
419 Added 0.12%
336,618 $34.6 Million
Q2 2020

Aug 07, 2020

BUY
$90.75 - $104.91 $25.8 Million - $29.8 Million
284,503 Added 550.34%
336,199 $33.2 Million
Q1 2020

Apr 28, 2020

SELL
$79.09 - $114.05 $695,992 - $1 Million
-8,800 Reduced 14.55%
51,696 $4.69 Million
Q4 2019

Feb 12, 2020

SELL
$77.9 - $98.54 $1.22 Million - $1.54 Million
-15,673 Reduced 20.58%
60,496 $5.86 Million
Q3 2019

Oct 29, 2019

SELL
$74.21 - $82.92 $59,813 - $66,833
-806 Reduced 1.05%
76,169 $6 Million
Q2 2019

Jul 30, 2019

SELL
$68.24 - $75.87 $291,384 - $323,964
-4,270 Reduced 5.26%
76,975 $5.81 Million
Q1 2019

Apr 22, 2019

SELL
$65.72 - $71.66 $471,015 - $513,587
-7,167 Reduced 8.11%
81,245 $5.63 Million
Q4 2018

Jan 25, 2019

SELL
$61.31 - $73.73 $155,298 - $186,758
-2,533 Reduced 2.79%
88,412 $5.76 Million
Q3 2018

Oct 24, 2018

SELL
$71.66 - $82.93 $251,383 - $290,918
-3,508 Reduced 3.71%
90,945 $6.62 Million
Q2 2018

Jul 09, 2018

SELL
$58.93 - $74.24 $208,435 - $262,586
-3,537 Reduced 3.61%
94,453 $6.72 Million
Q1 2018

May 11, 2018

SELL
$54.51 - $65.8 $5.14 Million - $6.2 Million
-94,216 Reduced 49.02%
97,990 $5.84 Million
Q1 2018

Apr 19, 2018

BUY
$54.51 - $65.8 $4.76 Million - $5.74 Million
87,275 Added 83.17%
192,206 $11.5 Million
Q4 2017

Jan 24, 2018

BUY
$52.25 - $56.32 $24,818 - $26,752
475 Added 0.45%
104,931 $5.8 Million
Q3 2017

Oct 17, 2017

BUY
$49.7 - $54.38 $5.19 Million - $5.68 Million
104,456
104,456 $5.49 Million

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.